Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus

被引:6
作者
Song, Do Kyeong [1 ]
Hong, Young Sun [1 ]
Sung, Yeon-Ah [1 ]
Lee, Hyejin [1 ]
机构
[1] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea
关键词
CAUSE-SPECIFIC MORTALITY; MULTIFACTORIAL INTERVENTION; BLOOD-PRESSURE; DISEASE; OUTCOMES;
D O I
10.1371/journal.pone.0299035
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Since patients with type 2 diabetes mellitus (T2DM) have an increased risk of cardiovascular events, interventions addressing risk factors reduce the incidence of cardiovascular disease (CVD) events. This study aimed to evaluate the difference in the incidence of CVD events according to risk factor control in patients with diabetes with and without cardio-renal disease.Methods We analyzed 113,909 patients with diabetes and 290,339 without diabetes using data released by the National Health Insurance Service (NHIS).Results Among patients with diabetes with four or five poorly controlled risk factors, hazard ratio for CVD events was 1.19 (95% confidence interval [CI], 1.06-1.34) in patients with cardio-renal disease and 2.31 (95% CI, 1.95-2.74) in patients without cardio-renal disease compared to patients with diabetes without risk factors. In subjects with diabetes and cardio-renal disease, patients with four or five poorly controlled risk factors had a higher risk of CVD mortality compared to subjects without risk factors (hazard ratio, 1.64; 95% CI, 1.18-2.30).Conclusion Controlling cardiovascular risk factors reduced the incidence of CVD events in patients with diabetes, especially those without cardio-renal disease. The degree of risk control was strongly associated with CVD mortality in patients with diabetes with baseline cardio-renal disease.
引用
收藏
页数:11
相关论文
共 25 条
[1]   10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022 [J].
American Diabetes Association Professional Practice Committee .
DIABETES CARE, 2022, 45 :S144-S174
[2]   9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022 [J].
American Diabetes Association Professional Practice Committee .
DIABETES CARE, 2022, 45 :S125-S143
[3]   Comprehensive Cardiovascular Risk Factor Control Improves Survival The BARI 2D Trial [J].
Bittner, Vera ;
Bertolet, Marnie ;
Felix, Rafael Barraza ;
Farkouh, Michael E. ;
Goldberg, Suzanne ;
Ramanathan, Kodangudi B. ;
Redmon, J. Bruce ;
Sperling, Laurence ;
Rutter, Martin K. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (07) :765-773
[4]   Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].
Gaede, P ;
Vedel, P ;
Larsen, N ;
Jensen, GVH ;
Parving, H ;
Pedersen, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393
[5]   Effect of a multifactorial intervention on mortality in type 2 diabetes [J].
Gaede, Peter ;
Lund-Andersen, Henrik ;
Parving, Hans-Henrik ;
Pedersen, Oluf .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) :580-591
[6]   Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study [J].
Gaede, Peter ;
Oellgaard, Jens ;
Kruuse, Christina ;
Rossing, Peter ;
Parving, Hans-Henrik ;
Pedersen, Oluf .
DIABETOLOGIA, 2019, 62 (09) :1575-1580
[7]   Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial [J].
Gde, Peter ;
Oellgaard, Jens ;
Carstensen, Bendix ;
Rossing, Peter ;
Lund-Andersen, Henrik ;
Parving, Hans-Henrik ;
Pedersen, Oluf .
DIABETOLOGIA, 2016, 59 (11) :2298-2307
[8]   2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [J].
Grundy, Scott M. ;
Stone, Neil J. ;
Bailey, Alison L. ;
Beam, Craig ;
Birtcher, Kim K. ;
Blumenthal, Roger S. ;
Braun, Lynne T. ;
de Ferranti, Sarah ;
Faiella-Tommasino, Joseph ;
Forman, Daniel E. ;
Goldberg, Ronald ;
Heidenreich, Paul A. ;
Hlatky, Mark A. ;
Jones, Daniel W. ;
Lloyd-Jones, Donald ;
Lopez-Pajares, Nuria ;
Ndumele, Chiadi E. ;
Orringer, Carl E. ;
Peralta, Carmen A. ;
Saseen, Joseph J. ;
Smith, Sidney C., Jr. ;
Sperling, Laurence ;
Virani, Salim S. ;
Yeboah, Joseph .
CIRCULATION, 2019, 139 (25) :E1082-E1143
[9]   Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes [J].
Kalyani, Rita R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13) :1248-1260
[10]   Blood Pressure and Development of Cardiovascular Disease in Koreans With Type 2 Diabetes Mellitus [J].
Kim, Mee Kyoung ;
Han, Kyungdo ;
Koh, Eun Sil ;
Kim, Eun Sook ;
Lee, Min-Kyung ;
Nam, Ga Eun ;
Kwon, Hyuk-Sang .
HYPERTENSION, 2019, 73 (02) :319-326